REFERENCES:
1. Lim HS. The Effect of Impella CP on Cardiopulmonary Physiology During Venoarterial Extracorporeal Membrane Oxygenation Support. Artif Organs 2017;41(12):1109-12.
2. Sabra MJ, Andrews WG, Crandall ML, et al. The postoperative use of Impella as a ventricular assist device in high-risk patients undergoing coronary artery bypass surgery: A case series and comparison. J Card Surg 2020;35(1):113-117.
3. Schibilsky D, Lausberg H, Haller C, et al. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access. Artif Organs 2015;39(8):660-3.
4. Grajeda Silvestri ER, Pino JE, Donath E, et al. Impella to unload the left ventricle in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock: A systematic review and meta-analysis. J Card Surg 2020;35(6):1237-1242.
5. Madjarov JM, Katz MG, Fazal S, et al. Mechanical circulatory support with extracorporeal membrane oxygenation and Impella 5.5 in patients with a postinfarction VSD: Combined or separate assist strategy? J Card Surg 2020;Nov 22. doi: 10.1111/jocs.15204.
6. Yin MY, Wever-Pinzon O, Mehra MR, et al. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant 2019;38(8):858-869.
7. Sef D, Mohite P, De Robertis F, et al. Bridge to heart transplantation using the Levitronix CentriMag short-term ventricular assist device. Artif Organs 2020 Sep;44(9):1006-1008.
8. Wong ASK, Sin SWC. Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review. Ann Transl Med 2020;8(13):829.
9. Dixon SR, Henriques Jose PS, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2009;2(2):91-6.
10. Alushi B, Douedari A, Froehlig G, et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart 2019;6(1):e000987.
11. Ouweneel DM, Eriksen E, Seyfarth M, Henriques Jose PS. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for Treating Cardiogenic Shock: Meta-Analysis. J Am Coll Cardiol 2017;69(3):358-360.
12. Barge-Caballero E, Almenar-Bonet L, Gonzalez-Vilchez F, et al. Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry. Eur J Heart Fail 2018;20(1):178-186.
13. Iannaccone M, Albani S, Giannini F, et al. Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies. Int J Cardiol, 2020. Sep 22;pii: S0167-5273(20)33825-0. doi: 10.1016/j.ijcard.2020.09.044.
14. Chandola R, Cusimano R, Osten M, Horlick E. Severe aortic insufficiency secondary to 5L Impella device placement. J Card Surg 2012;27(3):400-2.
15. Hong E, Naseem T. Color Doppler Artifact Masking Iatrogenic Aortic Valve Injury Related to an Impella Device. J Cardiothorac Vasc Anesth 2019;33(6):1584-1587.
16. Vila P, de Vere F, Simon A, Walker C. Severe aortic valve regurgitation requiring mechanical aortic valve replacement following Impella device implantation. Perfusion 2020; Jul 15:267659120941339. doi: 10.1177/0267659120941339. Epub ahead of print.
17. Sharma S, Briasoulis A, Afonso L. Persistent aortic insufficiency secondary to Impella device implantation. Int J Cardiol 2014;176(1):e9-10.
18. Butala B, Yu R, Schorr R, Gologorsky E. Periprocedural Dynamics of Aortic Regurgitation in Patients Supported With an Impella Left Ventricular Assist Device. J Cardiothorac Vasc Anesth 2020;34(3):659-662.
19. Bhatia N, Richardson TD, Coffin ST, Keebler ME. Acute Mitral Regurgitation After Removal of an Impella Device. Am J Cardiol 2017;119(8):1290-1291.
20. Khalid N, Shlofmitz E, Case BC, Waksman R. Chordae Tendineae Rupture and Iatrogenic Severe Mitral Regurgitation Related to Impella. EuroIntervention 2020; Feb 18;EIJ-D-19-00942. doi: 10.4244/EIJ-D-19-00942. Epub ahead of print.
21. Pivato CA, Ferrante G, Briani M, Sanz Sanchez J, Reimers B, Pagnotta P. Mitraclip treatment for severe mitral regurgitation due to chordae rupture following Impella CP support in a patient with severe aortic stenosis. Cardiovasc Revasc Med 2020; Aug 15:S1553-8389(20)30496-6. doi: 10.1016/j.carrev.2020.08.027. Epub ahead of print.
22. Elhussein TA, Hutchison SJ. Acute mitral regurgitation: unforeseen new complication of the Impella LP 5.0 ventricular assist device and review of literature. Heart Lung Circ 2014;23(3):e100-4.
23. O’Neill WW, Schreiber T, Wohns DH, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 2014;27(1):1-11.
24. Toggweiler S, Jamshidi P, Erne P. Functional mitral stenosis: a rare complication of the Impella assist device. Eur J Echocardiogr 2008;9(3):412-3.